China NMPA Approves Funakizumab Injection for Moderate-to-Severe Plaque Psoriasis

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#NMPA #DrugApproval #MonoclonalAntibody #IL17A #Psoriasis #BiopharmaChina #InnovativeDrug

China NMPA Approves Spuqibai Monoclonal Antibody Injection for Market

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#KeymedBio #StapokibartInjection #InnovativeDrugs #AtopicDermatitis #IL4RAntibody #BiopharmaChina #BiotechInnovation #ChinesePharmaceuticals #DrugApproval #Biologics